ライフサイエンスコーパス: risk assessment

1 enotoxicants and can serve as biomarkers for risk assessment.

2 ning restoration strategies and human health-risk assessment.

3 is suitable for high-throughput ranking and risk assessment.

4 inic for pre-cancer treatment cardiovascular risk assessment.

5 unresolved how to address metal mixtures in risk assessment.

6 assays is a major challenge in environmental risk assessment.

7 in human disease and to inform human health risk assessment.

8 nnaire-based, microbiology-focused biosafety risk assessment.

9 of plant phenology in the models used for O3 risk assessment.

10 using physiological conditions for accurate risk assessment.

11 dress for biological relevance and necessary risk assessment.

12 entional and have tremendous implications in risk assessment.

13 of blood-based omic profiling in hazard and risk assessment.

14 mplications for environmental monitoring and risk assessment.

15 cancer diagnosis, prognosis, and recurrence risk assessment.

16 diagnostic gene panel testing for individual risk assessment.

17 an biomonitoring studies for OC exposure and risk assessment.

18 significantly improved global CVD and ASCVD risk assessment.

19 refore their health effects require separate risk assessment.

20 a is too sparse or uncertain for traditional risk assessment.

21 s were developed to facilitate point-of-care risk assessment.

22 e samples of airborne PAHs to improve health risk assessment.

23 n the context of epidemiological studies and risk assessment.

24 implications in therapeutic development and risk assessment.

25 inst second HSCT must be based on a thorough risk assessment.

26 roves the performance of identified POCOs in risk assessment.

27 Recalibration may be necessary for accurate risk assessment.

28 emerging discipline to support 21st-century risk assessment.

29 HAND in the HAART era and may contribute to risk assessment.

30 lability adjustments for use in human health risk assessment.

31 ging task, in particular in ecotoxicological risk assessment.

32 nd there is a need for better biomarkers for risk assessment.

33 and provide improved information for cancer risk assessment.

34 ngs open new frontiers for rational pandemic risk assessment.

35 xicants and an important biomarker for human risk assessment.

36 rming remains a key challenge for ecological risk assessment.

37 pathways (such as melanogenesis) in melanoma risk assessment.

38 al heat exposure information in research and risk assessment.

39 gand models (BLMs) for metals are useful for risk assessment.

40 hat enhances inference from static genotypic risk assessment.

41 s PMS2 and EPCAM to provide comprehensive LS risk assessment.

42 e of family history and mutation location in risk assessment.

43 sk factors can improve individualized stroke risk assessment.

44 , and these findings will help inform future risk assessment.

45 to reduce false-negative results and improve risk assessment.

46 ion test performance; harms of screening and risk assessment.

47 ividual variability is a challenging step in risk assessment.

48 t of tools and methods for MPs environmental risk assessment.

49 ing exposure concentrations in environmental risk assessments.

50 these differences may inform immunogenicity risk assessments.

51 inary drug residue stability for food safety risk assessments.

52 be used to prioritize cumulative toxicology risk assessments.

53 Pathway which could be useful in Ecological Risk Assessments.

54 ng native field soils in bioavailability and risk assessments.

55 used in regulatory procedures and ecological risk assessments.

56 CI, 0.60 to 0.86) and Cancer of the Prostate Risk Assessment (0.74; 95% CI, 0.65 to 0.84), and 30% of

57 strategies for cardiovascular disease (CVD) risk assessment among adults without known CVD are limit

58 would improve global and atherosclerotic CVD risk assessment among individuals without known CVD.

59 sample collection, preparation and analysis; risk assessment analysis and publication) phases.

60 METHODS AND ROADMAP (Risk Assessment and Comparative Effectiveness of Left Ve

61 The prospective observational ROADMAP study (Risk Assessment and Comparative Effectiveness of Left Ve

62 h will contribute to further research on the risk assessment and control of biofilm-associated-pathog

63 and can be leveraged to improve personalized risk assessment and develop novel interventions to preve

64 icians are also better informed to determine risk assessment and develop preventative or plan interce

65 growth and toxigenesis are largely aimed at risk assessment and do not include explicit genetic info

66 agement review from their pharmacist and CVD risk assessment and education.

67 he calibration was established by an initial risk assessment and included anticipated variability fro

68 proving both the objectivity and accuracy of risk assessment and inform treatment decisions.Significa

69 n and anxiety disorders and may aid in early risk assessment and intervention.

70 Findings also indicate that personalized risk assessment and optimal treatment could reduce death

71 itically reviews the fundamental concepts of risk assessment and outcome prediction, as they relate t

72 newly emerging H3N2v viruses is critical for risk assessment and pandemic preparedness.

73 en tissues could contribute to normal tissue risk assessment and planning of remedial measures.

74 ture methodologies, and explore preventative risk assessment and policy decision-making that incorpor

75 the HA gene, which highlights challenges in risk assessment and public health management of IAV(H7N9

76 fers an opportunity to significantly improve risk assessment and reduce cost.

77 Application of the LEnS framework in risk assessment and regulation will improve protection o

78 ailable literature and current practices for risk assessment and state-of-the-science techniques in m

79 n as an essential prognostic tool for cancer risk assessment and the quantification of intratumoural

80 justed Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early

81 identified loci also have modest success in risk assessment and therefore are of limited practical u

82 fe to consume or have simply not undergone a risk assessment and therefore remain unlabelled for that

83 position of which must be known for adequate risk assessment and treatment.

84 eview provides perspectives in entomological risk assessment and vector control, challenges for both,

85 The resulting model can be used for global risk assessments and health studies, particularly in cou

86 for metals are widely applied in ecological risk assessments and in the development of regulatory wa

87 providing real world data which could guide risk assessments and policy designed to ensure the safe

88 ide the bulk of experimental data for future risk assessments and will require quantitative physiolog

89 ty of infection using quantitative microbial risk assessment, and calculate the subsequent burden of

90 tudy-highlights of findings, applications to risk assessment, and future directions.

91 rizes our findings, suggests applications to risk assessment, and identifies strategic research direc

92 ed medicine and nutrition, inform toxicology risk assessment, and improve drug discovery and developm

93 , water quality data, quantitative microbial risk assessment, and pathogen prevalence in an agent-bas

94 TER score provides a readily available VLRAF risk assessment, and performs better than other scores.

95 high-risk primary prevention based on formal risk assessment, and primary prevention based on single

96 genetic family screening, genotype-informed risk assessment, and tailored strategies for early diagn

97 f human exposure to chemicals in food, sound risk assessments, and more focused risk abatement strate

98 urdens, data limitations, vulnerabilities in risk assessments, and recurring corporate lawsuits.

99 affect apical end points used in regulatory risk assessments, and without mechanistic data, an endoc

100 , thoughtful application of new knowledge to risk assessment appears reasonable for augmenting major

101 This study evaluates the risk assessment approach currently employed for polycycl

102 he foundations of a predictive human mixture risk assessment approach for anti-androgenic exposures i

103 Current sediment risk assessment approaches consider acid-volatile sulfid

104 al to protecting public health, and chemical risk assessments are used to inform public health decisi

105 products produced in the European Union and risk assessment associated with the consumption of these

106 ncludes with the notion that accurate caries risk assessment at the population level and "precision d

107 Risk assessment based on 2 childhood lipid measures and

108 arsenic species in turkey meat: exposure and risk assessment based on a 2014 U.S. market basket sampl

109 Besides, our risk assessment based on AOT40 shows a good consistency

110 Conversely, risk assessment based on stomatal O3 uptake shows differ

111 describe a new mouse model suitable for such risk assessment, based on the observation that the innat

112 onomic intervention facilitated sampling and risk assessment before and after infection.

113 ro-B-type natriuretic peptide provides early risk assessment beyond clinical variables in patients wi

114 s to apply the exposome to children's health risk assessment by introducing the concept of Lifestage

115 deration of all exposure routes for upcoming risk assessment by the U.S. Environmental Protection Age

116 re to mixtures is difficult to estimate, and risk assessment by whole mixture potency evaluations has

117 At low-effect levels important in risk assessments, CA overestimated mixture toxicity to d

118 more accurately than prior history and that risk assessment can be improved by biomarkers of organ i

119 ls that need to be considered when improving risk assessment: carry-over effects on adult fitness can

120 and can provide insights for epidemiological risk assessment concerning extreme heat.

121 Cumulative risk assessments consider multiple stressors but it is i

122 Cumulative risk assessment (CRA) methods promote the use of a conce

123 ly relevant conditions and provide realistic risk assessment data.

124 A protein-based risk assessment embedded within a large proteomic survey

125 Current environmental risk assessments (ERA) do not account explicitly for eco

126 ry useful for analytical laboratory control, risk assessment, establishment of maximum limits, develo

127 Quantitative human health risk assessment estimated the excess lifetime cancer ris

128 ing twice a week and biological sampling and risk assessment every 3 months during participation in a

129 ng approach than that used in the regulatory risk assessment exhibits a higher level of protectivenes

130 magna, a model organism in ecotoxicology and risk assessment, exposed to the toxic cyanobacterium Mic

131 This SSI risk assessment factor provides a simple tool using read

132 Traditional chemical risk assessments focus on health effects of environmenta

133 The need for an environmental risk assessment for engineered nanomaterials (ENM) neces

134 e clarification of disease etiology, improve risk assessment for ESRD, and pave the way for personali

135 l of Raman spectroscopy to provide objective risk assessment for future cardiometabolic complications

136 Chief among the uncertainties in risk assessment for NA is whether human lung CYP2A13 and

137 ritical to the periodontist when determining risk assessment for patients undergoing orthodontic ther

138 findings may guide monitoring decisions and risk assessment for pregnant women with CHD at the time

139 est the proposed framework in the context of risk assessment for seven complex diseases, type 1 diabe

140 ultimarker risk score significantly enhanced risk assessment for stroke, systemic embolic events, or

141 mproving feasibility of routine preoperative risk assessment for surgical patients.

142 fits and harms of preeclampsia screening and risk assessment for the US Preventive Services Task Forc

143 For this reason, the use of PODY in the O3 risk assessment for vegetation is becoming recommended.

144 on dispersal processes is largely ignored in risk assessments for crop diseases, as inoculum is gener

145 vide a quantitative evaluation of extinction risk assessments for species, allow for identification o

146 s (VA/DoD CPG) require comprehensive suicide risk assessments for VA/DoD patients with mental disorde

147 biological interactions in a high-throughput risk-assessment framework.

148 evealed a network consisting of 18 mortality risk assessment genes related to tumor protein 53 (TP53)

149 he proteins directly related to 80 mortality risk assessment genes.

150 Curiously, comprehensive risk assessments have increasingly explored effects on n

151 inary care team, patient navigators provided risk assessment, health education, treatment readiness a

152 h the accuracy of pre-pandemic and real-time risk assessments hinging on reliable seasonal influenza

153 nty and lack of exposure data prevent a full risk assessment; however, the results of this analysis p

154 Human health risks via Health Risk Assessment (HRA) were conducted to understand expos

155 clinical use of NAG ratio in cardiovascular risk assessment in a low-risk group.

156 ical context is crucial for a more realistic risk assessment in a warming world.

157 Whether risk assessment in black adults is dissimilar to that in

158 aRE consortium (Biomarker for Cardiovascular Risk Assessment in Europe), we examined AF incidence, it

159 NM exposure and effect and may be useful for risk assessment in foods and in the environment.

160 Our findings provide information for risk assessment in Ga-contaminated soil.

161 e to currently existing diagnostic tools for risk assessment in myocarditis.

162 sk score may serve as the first step for CVD risk assessment in primordial prevention.

163 he potential use of GlycA in subclinical CVD risk assessment in psoriasis and potentially other infla

164 relate with PFS and OS and could be used for risk assessment in stage I-II NSCLC.

165 cade, suggesting a role for the CAC score in risk assessment in such patients.

166 d to the predictive value of baseline CT and risk assessment in terms of C-statistic or integrated di

167 s are needed to develop objective models for risk assessment in these fetuses.

168 nd obese individuals, and offer a method for risk assessment in this susceptible population of heavie

169 pted for other pathogens and used to provide risk assessments in real-time (3) .

170 bioaccumulation models to predict hazard and risk assessments in the Anthropocene.

171 f several crucial aspects of MP exposure and risk assessment, including the quantification of emissio

172 To evaluate an inpatient pediatric fall risk assessment index, known as the Little Schmidy, and

173 on clinical outcomes or the effectiveness of risk assessment instruments; the harms of screening; or

174 sensitivity in pass rates included coronary risk assessment, international normalized ratio measured

175 % (antihypertensive class) to 100% (coronary risk assessment; international normalized ratio measured

176 Cardiovascular risk assessment is a fundamental component of prevention

177 Quantitative Microbial Risk Assessment is a suggested path forward because such

178 ent tools and processes used for its benefit-risk assessment is critical.

179 The potential for extrapolating the model to risk assessment is discussed.

180 Therefore, preoperative risk assessment is needed to identify high-risk patients

181 stomatal flux-based index, large-scale ozone risk assessment is still complicated by a large and unex

182 This commentary discusses scientific and risk assessment issues that impact the development of dr

183 explanatory and predictive power in disease risk assessments, leading to improved recommendations fo

184 Perhaps the future of HFpEF risk assessment lies in a multimodality approach that co

185 Atherothrombotic risk assessment may be useful to identify high-risk pati

186 and non-invasive personalized virtual heart risk assessment may have the potential to prevent SCD an

187 weight of evidence approaches to ecological risk assessment may not account for uncertainties and ge

188 Evidence-based risk assessments may improve patient safety and reduce r

189 ir free-text descriptions, using a published risk assessment method, we classified 43 (16%) as having

190 Current pediatric falls risk assessment methods have poor precision and accuracy

191 a useful proxy for organism fitness and that risk assessment methods should be revised as they curren

192 reatment history in non-suicidal self-injury risk assessments might hold particular value in communit

193 In the frame of risk assessment, mixed in silico/in vitro approaches alr

194 We present an applied domoic acid risk assessment model for the US West Coast based on com

195 A comparative risk assessment model incorporated data and correspondin

196 We developed a comparative risk assessment model to estimate the UK health impact o

197 en and no advanced disease, we built a novel risk assessment model-based on age and SD OCT segmentati

198 were the inputs of a Quantitative Microbial Risk Assessment model.

199 Among 45 examined variables, the final risk-assessment model contained 10 categorical variables

200 icantly outperforms individual variant based risk assessment models as well as the state-of-the-art p

201 We aimed to build SD OCT-based risk assessment models for 5-year new onset of GA and ce

202 The existing risk assessment models for H9N2 viruses in ferrets may n

203 se MOA classification in chemical hazard and risk assessment more broadly.

204 We performed a congener-specific mixture risk assessment (MRA) of human exposure to combinations

205 The Next Generation of Risk Assessment multiyear study-highlights of findings,

206 A simple and fast method was developed for risk assessment of As, Cr, and Se in food, which is demo

207 se data represent an important input for the risk assessment of blood-borne prion disease transmissio

208 ey also represent an important input for the risk assessment of blood-borne prion disease transmissio

209 rter-carrying mouse may be able to provide a risk assessment of cachexia, with possible implications

210 prediction models to provide a point-of-care risk assessment of cACLD patients.

211 Clinical risk factors form the basis for risk assessment of cardiovascular disease and the additi

212 odities and Trade (IMPACT), to a comparative risk assessment of changes in fruit and vegetable consum

213 d by children and to perform a more accurate risk assessment of children's exposure to mycotoxins mix

214 egulatory functions that are relevant to the risk assessment of estrogenic compounds.

215 development of environmental monitoring and risk assessment of FPW spills.

216 rtainty poses a significant challenge to the risk assessment of geological carbon storage.

217 dose approach has not yet been validated for risk assessment of individual patients.

218 four different cohorts were analyzed for the risk assessment of locoregional recurrences (LR) and dis

219 on internal dose was evaluated as a tool for risk assessment of metal mixture.

220 nd they are thus particularly useful for the risk assessment of metals in aquatic systems.

221 of nanomaterial toxicity and thus inform the risk assessment of nanoparticles in a timely fashion.

222 ce to digestion can be used in allergenicity risk assessment of novel food proteins, including GMOs.

223 that may facilitate future surveillance and risk assessment of novel influenza viruses.

224 ity for drug discovery and for environmental risk assessment of organic cations.

225 dditive assumption employed for human health risk assessment of PAH mixtures.

226 Current ecological risk assessment of pesticides fails to protect aquatic b

227 Current ecological risk assessment of pesticides fails to protect aquatic e

228 , we conclude that the current framework for risk assessment of pesticides is not protective against

229 Accurate preoperative risk assessment of postoperative mortality, overall morb

230 Benefit-risk assessment of such procedures should be on the basi

231 to mammalian hosts is important for a rapid risk assessment of such viruses soon after they cross th

232 target compounds can be used for read-across risk assessment of target compounds.

233 ity of arsenic depends on its chemical form, risk assessments of arsenic exposure must consider the t

234 ocytes may be a unique set of biomarkers for risk assessments of SCC and UC.

235 transfer between liquid and skin and guides risk assessments of water-related activities.

236 harge mortality risk, allowing comprehensive risk assessment on admission.

237 se arable soils, which will allow data-based risk assessment on their use.

238 l diagnosis of stroke makes a simple genetic risk assessment only partially informative on an individ

239 The current single-chemical-as-carcinogen risk assessment paradigm might underestimate or miss the

240 As such, these data provide a preclinical risk assessment paradigm, including a clinically relevan

241 use population resources in each step of the risk assessment paradigm.

242 g that LDL-c reduction may provide a dynamic risk assessment parameter for new-onset diabetes.

243 ent years but lacks practical application to risk assessment, particularly for children's health.

244 pesticides and trace elements in meat from a risk assessment perspective.

245 rency, and usefulness of decision making for risk assessments prepared by agencies of the U.S. federa

246 dontic tooth movement and can help determine risk assessment prior to such intervention.

247 ansgenerational epigenetic heritability into risk assessment procedures has been previously suggested

248 of unlabelled products that have undergone a risk assessment process and to examine the factors influ

249 east 30% of products may have been through a risk assessment process and yet bear no PAL statement on

250 02/434) that had been through the VITAL((R)) risk assessment process had no PAL statement on the labe

251 that had undergone another (non-VITAL((R)) ) risk assessment process had no PAL statement.

252 ith VTE also had higher mean (SD) Greenfield Risk Assessment Profile scores (12 [4] vs 7 [4]; P < .00

253 ith VTE also had higher mean (SD) Greenfield Risk Assessment Profile scores (13 [6] vs 8 [4]; P </= .

254 athogen measurements, quantitative microbial risk assessment (QMRA) methods were employed to assess t

255 ed model outputs in a quantitative microbial risk assessment (QMRA) to estimate risk [probability of

256 r exploration through quantitative microbial risk assessment (QMRA).

257 questionnaires, we developed a quantitative risk assessment (QRA) model for the anchovy value chain.

258 portunity for integration of screening-level risk assessment (RA) with LCA.

259 aterials' safety is evaluated using chemical risk assessment (RA).

260 Environmental risk assessment requires information about the toxicity

261 cancer screening and prevention, focusing on risk assessment, screening, prevention, and practice imp

262 directed detection as bioanalytical tool for risk assessment showed coumarin to be active against Ali

263 The data monitoring committee criterion for risk assessment (significant difference in serious grade

264 s on growth, underscoring the need for novel risk assessment strategies for this chemical in the aqua

265 cultures would further strengthen the future risk-assessment strategies.

266 nd gaps of knowledge required to improve the risk assessment strategy.

267 Yet, most toxicity threshold and risk assessment studies are based on invertebrates and f

268 ts provide insights to design more efficient risk assessment studies expanding knowledge over the gro

269 n of plant growing season; actually, in many risk assessment studies, this function is based on a sim

270 We used data from a 4-y longitudinal caries-risk assessment study carried out among Scottish childre

271 Applying the MPFs in cancer risk assessment suggested that 45.4 (6% of all) cancer c

272 me of each measurement, patients completed a risk assessment survey that reported the number of blood

273 lifestyle risk factors examined through the risk assessment survey were significantly associated wit

274 ributory to a microbiology-focused biosafety risk assessment than information on the specimen source

275 ugh there is considerable uncertainty in the risk assessment, the geographic patterns of the risk are

276 tory of spine or hip fracture, or a Fracture Risk Assessment Tool (FRAX) score indicating increased f

277 are a screening programme using the Fracture Risk Assessment Tool (FRAX) with usual management.

278 breast cancer according to the Breast Cancer Risk Assessment Tool (Gail score).

279 A human immunodeficiency virus (HIV) risk assessment tool for pregnant women could identify w

280 than 3% (World Health Organization Fracture Risk Assessment Tool score, or FRAX), 10-year risk for m

281 ssion-based techniques were used to create a risk assessment tool to predict risk of postdischarge VT

282 ontal risk was analyzed with a periodontitis risk assessment tool, and microbiologic testing was perf

283 with the rest of the risk categories by the risk assessment tool.

284 having a "high" risk of periodontitis by the risk assessment tool.

285 use of the Million Hearts Longitudinal ASCVD Risk Assessment Tool.

286 There is currently no preoperative risk-assessment tool that allows physicians to estimate

287 These findings highlight the need for better risk assessment tools among young adults.

288 Quantitative risk assessment tools are not routinely used for preoper

289 Risk assessment tools for exercise treadmill testing may

290 INTERPRETATION: Our risk charts provide risk assessment tools that are recalibrated for each cou

291 hasize the need for effective monitoring and risk assessment tools to mitigate the potential environm

292 to move beyond diagnostics and mechanistical risk assessment, towards providing a foundation for pers

293 ve to single compounds suggest that previous risk assessments underestimate the effects of real world

294 cohort, the addition of CAC score to global risk assessment was associated with significantly improv

295 was generated, validation and calibration of risk assessment was done with nationwide data for the sa

296 To improve risk assessment, we need to evaluate the impact on BBB u

297 duals who had previously completed an online risk assessment were scored blindly and independently by

298 he emerging science and traditional chemical risk assessments were explored, and approaches for bridg

299 sue may represent a marker for breast cancer risk assessment, which may therefore impact the frequenc

300 nt metrics for exposure and effect can bring risk assessment within reach.